Cone M
International Federation of Pharmaceutical Manufacturers' Associations, Geneva, Switzerland.
J Clin Epidemiol. 1991;44 Suppl 2:45S-47S. doi: 10.1016/0895-4356(91)90112-m.
The IFPMA represents 51 member associations of national pharmaceutical manufacturers throughout the world. It has developed several programs to interface and communicate with the World Health Organisation (WHO) programmes especially in regard to its activities in developing countries. Examples of collaboration with WHO are the IFPMA Training Scheme in Quality Control run jointly with the Pharmaceuticals Unit of the WHO. The IFPMA has developed a Code of Pharmaceutical Marketing Practices. It contributes to the health of both the developed and developing world through industry research, development and production of new and improved medicines. IFPMA publications provide important technical information for the global pharmaceutical industry and deal with the important issues of rational drug use in the developing world.
国际制药商协会联合会代表着全球51个国家制药商成员协会。它制定了若干项目,以便与世界卫生组织(WHO)的项目进行对接和沟通,特别是在其于发展中国家开展的活动方面。与WHO合作的例子包括与WHO药品部门联合开展的国际制药商协会联合会质量控制培训计划。国际制药商协会联合会制定了《药品营销行为准则》。它通过行业对新药和改良药物的研发与生产,为发达国家和发展中国家的健康事业做出贡献。国际制药商协会联合会的出版物为全球制药行业提供重要的技术信息,并涉及发展中国家合理用药的重要问题。